Biosurfactants, BIO-TIC Business Case Workshops 2014, Berlin, Germany
A BIO-TIC business case workshop about the uptake of industrial biotechnology in biosurfactants, 3 September 2014 at Westin Grand Hotel, Berlin, Germany.
The BIO-TIC project has organised this workshop with the aim to identify technological, non-technological and market hurdles for the uptake of industrial biotechnology in biosurfactants and develop recommendations and solutions to overcome the identified hurdles.
Input from market, policy and technological experts is crucial to help us develop recommendations which best answer the needs of industry and further build on the roadmaps.
The biosurfactants workshop is a satellite event at the conference: “The 3rd ICIS European Surfactants Conference: -Understanding the key market drivers, trends, challenges and regulations impacting the region”,September 4-5, 2014, http://www.icisconference.com/EuropeanSurfactants which takes place in Lyon, France on 25-26 September, 2014.
Register for the biosurfactants workshop at http://bio-tic-workshops.eu/biosurfactants/.
BIO-TIC is a three year project, funded by the European Commission and coordinated by EuropaBio, aiming to identify the hurdles to Industrial Biotechnology (IB) and to develop solutions to overcome them, thereby unlocking the massive potential for this key technology in Europe.
The project focuses on five product groups which have significant potential for Europe and which have the potential to introduce cross cutting technology ideas. These product groups are:
- Bio-based chemical building blocks
- Bio-based plastics (PHA and PLA)
- Advanced biofuels
- CO2 based chemicals
Roadmaps for developing the IB sector in Europe, with a special focus on the opportunities above, will be delivered by summer 2015. We are developing three in depth bio-roadmaps focussing on market potential, R&D priorities and non-technological (regulatory and policy) hurdles to IB innovation. The market roadmap will provide market projections to 2030. The technological roadmap will focus on setting R&D priorities and identifying needs for pilot and demonstration activities and the non-technological issues roadmap will identify the regulatory and non-technological hurdles that may inhibit IB innovation from new markets.